Press Release Distribution

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for December 11, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   

Vista Healthcare, Inc. to Lead the Way to "Personalized Medicine" and Change the Future of Healthcare

Vista Healthcare, Inc., a private Pittsburgh based company, has expanded its pharmacogenomic testing technology nationwide to offer health systems and private practice physicians the opportunity to practice "personalized medicine".
x-small text small text medium text large text

    PITTSBURGH, PA, December 11, 2013 /24-7PressRelease/ -- Vista Healthcare, Inc. has moved forward to bring "personalized medicine" nationwide. Patient demand for these services has increased exponentially in recent years and Vista is making this technology as accessible to patients and physicians as possible.

Adverse drug events/reactions cost the healthcare system millions of dollars each year and lead to hundreds of thousands of serious injuries and hospitalizations. "With the implementation of our pharmacogenomic testing, physicians will be able to receive a 'blueprint' of how best to treat their patients with medications, thereby reducing or eliminating any non-response or adverse drug event from the prescribed medications", stated company Chief Science Officer Braden Dernoshek, Rph.

Vista Healthcare, Inc. has partnered with Affiliated Genetics, Inc. and is excited to offer this technology free-of-charge to physicians while having full coverage of testing through Medicare and all major private insurers.

About Vista Healthcare, Inc.

Vista Healthcare, Inc. is a private company specializing in marketing cutting-edge, FDA-approved medical modalities to health care systems and private practice physicians. We are currently focused on offering pharmacogenomic testing technology to physicians to decrease healthcare costs while increasing positive patient treatment outcomes.

For more information on Vista Healthcare, Inc. please contact Braden Dernoshek, Rph, Chief Science Officer at

Press release service and press release distribution provided by

# # #

Contact Information:
Braden Dernoshek
Vista Healthcare, Inc.

Pittsburgh, Pennsylvania
United states
Voice: 412-296-9850
E-Mail: Email us Here
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.